About the Journal

Insight is a peer-reviewed, diamond open-access journal published by the 786-MIII Medicine platform. Articles are published continuously online and gathered into monthly issues. There are no fees for authors and no fees for readers.

Insight publishes ultra-brief evidence updates, methodological innovations, and rapid meta-analytic reports where the goal is to put a defensible inference into a clinician's or policymaker's hands in minutes rather than hours. The E156 Research Letter is the journal's native form. Long-form methods and review pieces are accepted where the question merits more space.

Article types

Our encouraged default format is the E156 Research Letter: a 156-word abstract that is the paper. Long-form articles are equally welcome where the question or audience warrants more space.

  • E156 Research Letter (default, 156-word body)
  • Methods Paper (up to 3,000 words)
  • Narrative Review (up to 4,000 words)
  • Case-Based Teaching (up to 2,500 words)
  • Editorial (up to 1,500 words)
  • Viewpoint (up to 1,500 words)
  • Debate (paired, up to 1,200 words each)
  • Reply / Response (up to 800 words)

Policies overview

Detailed policies are published on the following pages:

Indexing & identifier readiness

ISSN application is in preparation; DOI/Crossref minting is planned; DOAJ, PMC, Scopus, and Web of Science applications will be staged once minimum publication history is in place. Google Scholar indexing is active. OAI-PMH is open at /index.php/insight/oai.

Peer Review Process

Insight follows a structured editorial and peer-review process aligned with the Committee on Publication Ethics (COPE). Each submission is first assessed by the editorial team for scope, completeness, and research integrity, then reviewed by individuals with relevant expertise who evaluate originality, methodological soundness, clarity, and significance. Final decisions rest with the editors and are based on the reviews and the scholarly merit of the work.

Publication Ethics and Malpractice Statement

Insight upholds high standards of publication ethics and follows COPE guidance. Authors, editors, and reviewers are expected to act with integrity. The journal addresses allegations of misconduct—including plagiarism, data fabrication or falsification, and redundant publication—and issues corrections, retractions, or expressions of concern where warranted.

Authorship

Authorship is limited to those who have made a substantial contribution to the conception, design, execution, or interpretation of the work. All listed authors approve the final version and agree to be accountable for it. Contributors not meeting authorship criteria are acknowledged.

Competing Interests

Authors must disclose any financial or non-financial competing interests that could be perceived to influence the work. Reviewers and editors recuse themselves from submissions in which they have a conflict of interest.

Data Availability

Authors are encouraged to make the data, code, and materials underlying their findings openly available where ethically and legally possible, and to include a data-availability statement.

Open Access and Licensing

Insight is a fully open-access journal. All articles are published under a Creative Commons Attribution 4.0 International License (CC BY 4.0), permitting use and redistribution with appropriate credit.